Pegavision Corporation

NT$392.50As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6491Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 20.91%
Div yield 2.55%
ROE 16.75%
Medical Instruments & Supplies
Beta (5Y) 0.70
PE TTM 15.53
TSR TTM 18.39%
Mkt cap NT$30.14B
ROIC 20.71%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$411
4.78%
(3.60%)
Hold 7|9|3|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
8.39
8.50
8.43
8.39
(2.04%)
(1.48%)
2.53%
6.66%
RevenueNT$B
2.852
2.858
2.925
2.935
16.71%
14.29%
14.32%
8.90%
Peers (US$910.4M)
Cap (US$)
PE
522.3M
16.78x
354.8M
13.29x
217.7M
12.30x
909.2M
19.79x
Capital
TTM
5Y
10Y
Leveragex
1.570
0.344
0.259
EBIT/Intx
0.163
0.367
0.327
Own earn%
(99.98)
(123.17)
(111.08)
Sh yield%
32.60
35.37
31.60
Owners
Insiders/Inst%
4.99
67.49
Short interest%
5.16
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
9